Engineered suppressor T cells overexpressing IFN-α and PD-L1 inhibit GVHD but retain GVL effects in mice
Authors:
- 15 November 2025
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 34 (2) , 898-915
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases (R01 AI143256)
- National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases (R37 AI034495)
- National Heart Lung and Blood Institute (R01 HL118979)
- National Heart Lung and Blood Institute (R01 HL154757)
- National Heart Lung and Blood Institute (R01 HL155114)
- National Institutes of Health
- National Cancer Institute Division of Cancer Epidemiology and Genetics (R01 CA290808)
This publication has 68 references indexed in Scilit:
- Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cellsImmunity, 2023
- Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacyCell Reports, 2022
- CMV Infection in Hematopoietic Stem Cell Transplantation: Prevention and Treatment StrategiesCurrent Treatment Options in Infectious Diseases, 2021
- A novel clinically relevant graft-versus-leukemia model in humanized miceJournal of Leukocyte Biology, 2021
- The role of type I interferons in CD4+ T cell differentiationImmunology Letters, 2019
- Plasmacytoid Dendritic Cells: Development, Regulation, and FunctionImmunity, 2019
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNature Medicine, 2018
- The diverse functions of the PD1 inhibitory pathwayNature Reviews Immunology, 2017
- De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell RejuvenationCell, 2017
- The origin of DCs and capacity for immunologic tolerance in central and peripheral tissuesSeminars in Immunopathology, 2016